查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1211011

全球出血性疾病測試市場規模和預測：按產品類型、適應症、最終用戶和地區分析，2022-2029

Global Bleeding Disorder Testing Market Size study & Forecast, by Product Type by Indication, by End-user and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球出血性疾病檢測市場價值約為 8260 萬美元，預計在 2022-2029 年預測期內將以超過 7.8% 的健康增長率增長。

出血性疾病是影響血液凝固過程的疾病，會導致出血過多。 這種疾病是由血液中凝血蛋白水平低引起的。 出血性疾病測試是一項篩查測試，用於檢測沒有疾病症狀的人的出血性疾病。 有利的報銷方案、人工智能和納米材料在測試和診斷中的日益整合以及不斷上升的醫療保健成本等因素是全球市場需求的主要驅動力。

普通人群中出血性疾病患病率和診斷率的上升正在推動市場增長。 根據美國疾病控制與預防中心的數據，估計每 5,000 名男性新生兒中就有 1 人患有 A 型血友病，每年約有 400 名嬰兒患有 A 型血友病。據說有 同樣，根據世界血友病聯合會 2020 年年度全球調查，全球約有 393,658 名出血性疾病患者，高於 2015 年的約 287,066 人。 這種激增是由於該病在普通人群診斷中的患病率上升，導致全球市場增長加速。 此外，主要市場參與者越來越多地推出新產品和增加研發投資，在預測期內提供了各種有利可圖的機會。 然而，血友病藥物的低指導合規率和高成本阻礙了整個 2022-2029 年預測期內的市場增長。

全球出血性疾病檢測市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於對指南的遵守程度不斷提高以及對這些疾病診斷的監管批准數量不斷增加，歐洲在收入方面佔據了市場主導地位。 另一方面，由於新興國家醫療基礎設施改善、出血性疾病患病率上升以及市場空間患者數量增加等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家中該行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年各地區出血性疾病檢測市場
    • 2019-2029 年按產品類型劃分的出血性疾病檢測市場
    • 出血性疾病檢測市場：按適應症分類，2019-2029 年
    • 出血性疾病檢測市場：按最終用戶分類，2019-2029 年
  • 主要趨勢
  • 調查方法介紹
  • 調查先決條件

第二章全球出血性疾病檢測市場的定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第3章出血性疾病檢測的全球市場動態

  • 出血性疾病檢測市場影響分析 (2019-2029)
    • 市場驅動因素
      • 加強人工智能和納米材料在測試和診斷方面的整合
      • 出血性疾病的患病率和診斷率增加
    • 市場挑戰
      • 準則遵從率低
      • 血友病藥物的高成本
    • 市場機會
      • 增加新產品的推出
      • 主要市場進入者增加研發投資

第 4 章全球出血性疾病檢測市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 頂級投資機會
  • 關鍵成功策略
  • 行業專家的展望
  • 分析師的結論和建議

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球出血性疾病檢測市場，按產品類型分類

  • 市場概況
  • 全球出血性疾病檢測市場：按產品類型、性能潛力分析
  • 2019-2029 年按產品類型分列的全球出血性疾病檢測市場、估計和預測
  • 出血性疾病檢測市場細分分析
    • 試劑和耗材
    • 設備

第 7 章：出血性疾病檢測的全球市場：按適應症分類

  • 市場概況
  • 全球出血性疾病檢測市場：按適應症、性能潛力分析
  • 2019-2029 年全球出血性疾病檢測市場、按適應症估計和預測
  • 出血性疾病檢測市場細分分析
    • A型血友病
    • 血友病B
    • 血管性血友病
    • 特發性血小板減少性紫癜
    • 其他

第 8 章全球出血性疾病檢測市場：按最終用戶分類

  • 市場概況
  • 全球出血性疾病檢測市場：最終用戶的性能潛力分析
  • 2019-2029 年全球出血性疾病檢測市場、最終用戶估計和預測
  • 出血性疾病檢測市場細分分析
    • 醫院和診所
    • 診斷中心
    • 其他

第 9 章全球出血性疾病檢測市場：區域分析

  • 出血性疾病檢測市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按產品類型估算和預測
      • 2019-2029 年各適應症的估計和預測
      • 2019-2029 年最終用戶的估計和預測
    • 加拿大
  • 歐洲出血性疾病檢測市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區出血性疾病檢測市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲出血性疾病檢測市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地區

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
      • 主要信息
      • 概覽
      • 財務信息（取決於數據可用性）
      • 產品概述
      • 近期趨勢
    • Siemens Healthcare GmbH
    • HORIBA Ltd.
    • Sysmex Corporation
    • Abbott
    • Thermo Fisher Scientific Inc.
    • Biomerica, Inc.
    • Becton, Dickinson, and Company
    • Quest Diagnostics
    • Trinity Biotech Plc

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Bleeding Disorder Testing Market is valued at approximately USD 82.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2022-2029. Bleeding disorder is a condition that affects when the blood clotting process and resulting in excessive bleeding. This disorder is caused by the low levels of clotting protein that is present in blood. Bleeding disorder testing is a screening test that is performed to detect bleeding disorders in people who have not shown any symptoms of disease. Factors such as favorable reimbursement scenarios, rising integration of artificial intelligence and nanomaterials in testing and diagnosis, coupled with the growing healthcare expenditure are the chief driving factors for the market demand around the world.

The increasing prevalence and diagnosis of bleeding disorder among general population is acting as a catalyzing factor for the growth of the market. According to The Centers for Disease Control and Prevention, it was estimated that Hemophilia A affects 1 in 5,000 male births and nearly 400 babies are born with hemophilia A each year. Likewise, as per the World Federation of Hemophilia's 2020 annual global survey, there were around 393,658 individuals worldwide recorded who suffer from bleeding disorders, which is an increase from about 287,066 in 2015. This surge occurs because of a rise in the disorder's prevalence among diagnoses in the general population, thus, in turn, accelerates the market growth across the globe. Moreover, the rising introduction of new products, as well as the growing R&D investment by the key market players are presenting various lucrative opportunities over the forecasting years. However, the low adherence to guidelines and high cost of hemophilia drugs are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bleeding Disorder Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe dominated the market in terms of revenue, owing to the rising adherence to the guidelines for diagnosis of these disorders and the rising number of regulatory approvals. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as development of healthcare infrastructure in emerging countries, rising prevalence of bleeding disorder, and rising number of patient population in the market space.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd.

Siemens Healthcare GmbH

HORIBA Ltd.

Sysmex Corporation

Abbott

Thermo Fisher Scientific Inc.

Biomerica, Inc.

Becton, Dickinson, and Company

Quest Diagnostics

Trinity Biotech Plc

Recent Developments in the Market:

  • In July 2022, HORIBA, Ltd. announced the launch of the company's new product Yumizen H500 and H550 hematology which offers better performance, new features, and increased benefits.
  • In February 2022, Sysmex Corporation unveiled the establishment of Sysmex LLC- the company's new subsidiary in Saudi Arabia. The aim of this initiative is to boost the sales and services structure in Saudi Arabia. The new subsidiary is emphasizing on strengthening its hemostasis, hematology, and urinalysis markets.

Global Bleeding Disorder Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Indication, End-user, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Reagents & Consumables

Instruments

By Indication:

Hemophilia A

Hemophilia B

Von Willebrand Disease

Idiopathic Thrombocytopenic Purpura

Others

By End-user:

Hospitals & Clinics

Diagnostic Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Bleeding Disorder Testing Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Bleeding Disorder Testing Market, by Product Type, 2019-2029 (USD Million)
    • 1.2.3. Bleeding Disorder Testing Market, by Indication, 2019-2029 (USD Million)
    • 1.2.4. Bleeding Disorder Testing Market, by End-user, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bleeding Disorder Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bleeding Disorder Testing Market Dynamics

  • 3.1. Bleeding Disorder Testing Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising integration of artificial intelligence and nanomaterials in testing and diagnosis
      • 3.1.1.2. Increasing prevalence and diagnosis of bleeding disorder
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low adherence to guidelines
      • 3.1.2.2. High cost of haemophilia drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising introduction of new products
      • 3.1.3.2. Growing R&D investment by the key market players

Chapter 4. Global Bleeding Disorder Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bleeding Disorder Testing Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Bleeding Disorder Testing Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Million)
  • 6.4. Bleeding Disorder Testing Market, Sub Segment Analysis
    • 6.4.1. Reagents & Consumables
    • 6.4.2. Instruments

Chapter 7. Global Bleeding Disorder Testing Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Bleeding Disorder Testing Market by Indication, Performance - Potential Analysis
  • 7.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by Indication 2019-2029 (USD Million)
  • 7.4. Bleeding Disorder Testing Market, Sub Segment Analysis
    • 7.4.1. Hemophilia A
    • 7.4.2. Hemophilia B
    • 7.4.3. Von Willebrand Disease
    • 7.4.4. Idiopathic Thrombocytopenic Purpura
    • 7.4.5. Others

Chapter 8. Global Bleeding Disorder Testing Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global Bleeding Disorder Testing Market by End-user, Performance - Potential Analysis
  • 8.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
  • 8.4. Bleeding Disorder Testing Market, Sub Segment Analysis
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Others

Chapter 9. Global Bleeding Disorder Testing Market, Regional Analysis

  • 9.1. Bleeding Disorder Testing Market, Regional Market Snapshot
  • 9.2. North America Bleeding Disorder Testing Market
    • 9.2.1. U.S. Bleeding Disorder Testing Market
      • 9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Bleeding Disorder Testing Market
  • 9.3. Europe Bleeding Disorder Testing Market Snapshot
    • 9.3.1. U.K. Bleeding Disorder Testing Market
    • 9.3.2. Germany Bleeding Disorder Testing Market
    • 9.3.3. France Bleeding Disorder Testing Market
    • 9.3.4. Spain Bleeding Disorder Testing Market
    • 9.3.5. Italy Bleeding Disorder Testing Market
    • 9.3.6. Rest of Europe Bleeding Disorder Testing Market
  • 9.4. Asia-Pacific Bleeding Disorder Testing Market Snapshot
    • 9.4.1. China Bleeding Disorder Testing Market
    • 9.4.2. India Bleeding Disorder Testing Market
    • 9.4.3. Japan Bleeding Disorder Testing Market
    • 9.4.4. Australia Bleeding Disorder Testing Market
    • 9.4.5. South Korea Bleeding Disorder Testing Market
    • 9.4.6. Rest of Asia Pacific Bleeding Disorder Testing Market
  • 9.5. Latin America Bleeding Disorder Testing Market Snapshot
    • 9.5.1. Brazil Bleeding Disorder Testing Market
    • 9.5.2. Mexico Bleeding Disorder Testing Market
    • 9.5.3. Rest of Latin America Bleeding Disorder Testing Market
  • 9.6. Rest of The World Bleeding Disorder Testing Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann-La Roche Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Siemens Healthcare GmbH
    • 10.2.3. HORIBA Ltd.
    • 10.2.4. Sysmex Corporation
    • 10.2.5. Abbott
    • 10.2.6. Thermo Fisher Scientific Inc.
    • 10.2.7. Biomerica, Inc.
    • 10.2.8. Becton, Dickinson, and Company
    • 10.2.9. Quest Diagnostics
    • 10.2.10. Trinity Biotech Plc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Bleeding Disorder Testing Market, report scope
  • TABLE 2. Global Bleeding Disorder Testing Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Bleeding Disorder Testing Market estimates & forecasts by Product Type 2019-2029 (USD Million)
  • TABLE 4. Global Bleeding Disorder Testing Market estimates & forecasts by Indication 2019-2029 (USD Million)
  • TABLE 5. Global Bleeding Disorder Testing Market estimates & forecasts by End-user 2019-2029 (USD Million)
  • TABLE 6. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Bleeding Disorder Testing Market
  • TABLE 71. List of primary sources, used in the study of global Bleeding Disorder Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Bleeding Disorder Testing Market, research methodology
  • FIG 2. Global Bleeding Disorder Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Bleeding Disorder Testing Market, key trends 2021
  • FIG 5. Global Bleeding Disorder Testing Market, growth prospects 2022-2029
  • FIG 6. Global Bleeding Disorder Testing Market, porters 5 force model
  • FIG 7. Global Bleeding Disorder Testing Market, pest analysis
  • FIG 8. Global Bleeding Disorder Testing Market, value chain analysis
  • FIG 9. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Bleeding Disorder Testing Market, regional snapshot 2019 & 2029
  • FIG 15. North America Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
  • FIG 19. Global Bleeding Disorder Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable